Heart Biomarker Evaluation in Apnea Treatment
| Status: | Archived |
|---|---|
| Conditions: | Insomnia Sleep Studies, Peripheral Vascular Disease, Cardiology, Pulmonary |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2010 |
| End Date: | April 2011 |
Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity
This study examines the role of sleep apnea treatment in improving cardiovascular
biomarkers.
This is a Phase II randomized controlled trial that will evaluate the effects of
supplemental nocturnal oxygen or Positive Airway Pressure (PAP) therapy, compared to optimal
medical preventive therapy for Cardiovascular Disease (CVD) risk, on biomarkers of CVD risk
in Obstructive Sleep Apnea (OSA) patients at high risk for CVD events. The study will focus
on patients with moderate to severe OSA but only mild OSA symptoms.
Eligible participants have a history or symptoms of heart disease AND have symptoms of sleep
apnea or snoring. Participants will be contributing to medical knowledge about different
options that can be used to improve heart disease in people with sleep apnea.
We found this trial at
4
sites
Click here to add this to my saved trials
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
Click here to add this to my saved trials
Click here to add this to my saved trials
Case Western Reserve Univ Continually ranked among America's best colleges, Case Western Reserve University has...
Click here to add this to my saved trials